Innovator behind Tylenol dies
This article was originally published in The Tan Sheet
Executive SummaryRobert L. McNeil Jr., the grandson of the founder of McNeil Laboratories and the driving force behind the launch of the first widely marketed non-aspirin OTC pain reliever, dies at age 94. McNeil, who remained with McNeil Laboratories when Johnson & Johnson acquired it in 1959 before retiring in 1964, died of heart failure on May 20 at his home in Wyndmoor, Pa. In 1936, he joined the firm his grandfather started in 1897, according to an obituary published by Kirk and Nice Funeral Homes. McNeil spearheaded the development of Butisol drugs, led the team that created Tylenol and named the active ingredient acetaminophen. Tylenol remains an iconic OTC brand
You may also be interested in...
The Committee on Energy and Commerce of the US House of Representatives has requested a set of documents from the FDA in order to assess whether the agency is doing enough to address the challenge of approving complex generics within its existing authorities, or whether additional authority is needed.
As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.